Prostat cancer is a disease which is the most common and which is also the second deadly in men. When prostat cancer can be diagnosed ear v, medical surgery operation can be performed and the disease can be treated. In this study, the aim is to design a classifier based expert system for ear v diagnosis of the organ in constraint phase. The other purpose is to reach informed decision making without biopsy by using following risc factors; PSA (Prostate Spesific Antigen), Free PSA, prostate volume, prostate density, weight, height, BMI (Body Mass Index), smoking and heart-rate. In other words, We want to diagnose cancer in optimum level where decrease the number of patients to whom applied biopsy The other purpose is to investigate a relation...
Background: The percentage of free prostate-specific antigen (%fPSA) has been shown to improve speci...
Prostate cancer is the century disease that endanger the life of men. The earlier to diagnose the di...
Background: We developed an artificial neural network (ANN) model to predict prostate cancer patholo...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
14th National Biomedical Engineering Meeting -- MAY 20-22, 2009 -- Izmir, TURKEYWOS: 000274345400048...
2009 14th National Biomedical Engineering Meeting, BIYOMUT 2009 -- 20 May 2009 through 22 May 2009 -...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
WOS: 000263817100074The aim of this study is to design a classifier based expert system for early di...
Prostatic carcinoma is the fifth most common cancer in the world and the second most common in men. ...
Purpose: In majority of patients who are subjected to prostate biopsies, no prostate cancer (PCa) is...
The prostate cancer is second-most leading cause of cancer-related death in the world, and a better ...
As medical science and technology progress towards the era of “big data”, a multi-dimensional datase...
AbstractBackgroundWe developed an artificial neural network (ANN) model to predict prostate cancer p...
Background: The percentage of free prostate-specific antigen (%fPSA) has been shown to improve speci...
Prostate cancer is the century disease that endanger the life of men. The earlier to diagnose the di...
Background: We developed an artificial neural network (ANN) model to predict prostate cancer patholo...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
14th National Biomedical Engineering Meeting -- MAY 20-22, 2009 -- Izmir, TURKEYWOS: 000274345400048...
2009 14th National Biomedical Engineering Meeting, BIYOMUT 2009 -- 20 May 2009 through 22 May 2009 -...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
Prostat cancer is a disease which is the most common and which is also the second deadly in men. Whe...
WOS: 000263817100074The aim of this study is to design a classifier based expert system for early di...
Prostatic carcinoma is the fifth most common cancer in the world and the second most common in men. ...
Purpose: In majority of patients who are subjected to prostate biopsies, no prostate cancer (PCa) is...
The prostate cancer is second-most leading cause of cancer-related death in the world, and a better ...
As medical science and technology progress towards the era of “big data”, a multi-dimensional datase...
AbstractBackgroundWe developed an artificial neural network (ANN) model to predict prostate cancer p...
Background: The percentage of free prostate-specific antigen (%fPSA) has been shown to improve speci...
Prostate cancer is the century disease that endanger the life of men. The earlier to diagnose the di...
Background: We developed an artificial neural network (ANN) model to predict prostate cancer patholo...